XFOR Insider Trading

Insider Ownership Percentage: 1.08%
Insider Buying (Last 12 Months): $30,000.00
Insider Selling (Last 12 Months): $749,326.27

X4 Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at X4 Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

X4 Pharmaceuticals Share Price & Price History

Current Price: $0.98
Price Change: Price Decrease of -0.0434 (-4.25%)
As of 06/17/2024 02:33 PM ET

This chart shows the closing price history over time for XFOR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

X4 Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/11/2024Adam S. MostafaCFOSell52,500$0.88$46,200.00View SEC Filing Icon  
3/11/2024Arthur TaverasInsiderSell14,235$0.88$12,526.80234,301View SEC Filing Icon  
3/11/2024Mary DibiaseCOOSell15,409$0.88$13,559.92291,752View SEC Filing Icon  
3/11/2024Paula RaganCEOSell49,678$0.88$43,716.64765,068View SEC Filing Icon  
2/12/2024Adam S. MostafaCFOSell27,721$1.01$27,998.2152,500View SEC Filing Icon  
2/12/2024Arthur TaverasInsiderSell787$1.01$794.87248,536View SEC Filing Icon  
2/12/2024Mary DibiaseCOOSell3,683$1.01$3,719.83307,161View SEC Filing Icon  
2/12/2024Paula RaganCEOSell21,695$1.01$21,911.95814,746View SEC Filing Icon  
11/3/2023Paula RaganCEOSell39,906$0.90$35,915.40836,441View SEC Filing Icon  
11/1/2023Adam S. MostafaCFOSell230,645$0.73$168,370.8580,221View SEC Filing Icon  
11/1/2023Mark BaldryInsiderSell10,257$0.73$7,487.6124,690View SEC Filing Icon  
11/1/2023Mary DibiaseCOOSell67,695$0.73$49,417.35310,844View SEC Filing Icon  
11/1/2023Paula RaganCEOSell199,531$0.73$145,657.63876,347View SEC Filing Icon  
9/8/2023Mary DibiaseCOOSell2,642$1.25$3,302.50147,894View SEC Filing Icon  
8/18/2023Michael S WyzgaDirectorBuy25,000$1.20$30,000.0076,667View SEC Filing Icon  
8/10/2023Murray StewartInsiderSell130,056$1.06$137,859.36146,504View SEC Filing Icon  
6/30/2023Adam S. MostafaCFOSell2,641$1.89$4,991.4980,221View SEC Filing Icon  
6/30/2023Mary DibiaseCOOSell464$1.89$876.96150,536View SEC Filing Icon  
6/23/2023Adam S. MostafaCFOSell5,417$1.93$10,454.8182,862View SEC Filing Icon  
6/23/2023Mary DibiaseCOOSell857$1.93$1,654.01151,000View SEC Filing Icon  
6/23/2023Paula RaganCEOSell6,724$1.92$12,910.08543,797View SEC Filing Icon  
6/15/2023Adam S. MostafaCFOSell5,417$2.22$12,025.7488,279View SEC Filing Icon  
6/15/2023Mary DibiaseCOOSell857$2.23$1,911.11151,857View SEC Filing Icon  
6/15/2023Paula RaganCEOSell6,724$2.23$14,994.52550,521View SEC Filing Icon  
5/31/2023Paula RaganCEOSell6,292$1.95$12,269.40557,245View SEC Filing Icon  
2/13/2023Adam S. MostafaCFOSell27,721$0.93$25,780.53146,196View SEC Filing Icon  
2/13/2023Arthur TaverasInsiderSell928$0.93$863.04103,179View SEC Filing Icon  
2/13/2023Mary DibiaseCOOSell4,348$0.93$4,043.64170,906View SEC Filing Icon  
2/13/2023Paula RaganCEOSell21,695$0.93$20,176.35613,215View SEC Filing Icon  
6/3/2022Paula RaganCEOSell6,292$1.21$7,613.32661,806View SEC Filing Icon  
8/17/2021Adam S. MostafaCFOSell10,832$5.10$55,243.20View SEC Filing Icon  
8/17/2021Derek M. MeisnerGeneral CounselSell8,332$5.10$42,493.20View SEC Filing Icon  
8/17/2021Paula RaganCEOSell13,448$5.10$68,584.80View SEC Filing Icon  
7/15/2021Paula RaganCEOSell13,448$5.78$77,729.44View SEC Filing Icon  
6/30/2021Adam S. MostafaCFOSell2,641$6.64$17,536.24View SEC Filing Icon  
6/24/2021Adam S. MostafaCFOSell5,417$7.01$37,973.17139,835View SEC Filing Icon  
6/24/2021Derek M MeisnerGeneral CounselSell4,166$7.00$29,162.0085,228View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for X4 Pharmaceuticals (NASDAQ:XFOR)

72.03% of X4 Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at XFOR by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

X4 Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/15/2024Price T Rowe Associates Inc. MD39,307$55K0.0%+46.7%0.023%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.7,827,727$10.88M0.0%-2.3%4.661%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC20,822$29K0.0%-56.3%0.012%Search for SEC Filing on Google Icon
5/3/2024GSA Capital Partners LLP321,021$0.45M0.0%-66.0%0.191%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets61,575$86K0.0%-78.3%0.037%Search for SEC Filing on Google Icon
3/18/2024Kingdon Capital Management L.L.C.3,473,683$2.91M0.4%+76.0%2.076%Search for SEC Filing on Google Icon
2/13/2024Bain Capital Life Sciences Investors LLC16,915,784$14.18M1.4%+6.0%10.112%Search for SEC Filing on Google Icon
2/13/2024Armistice Capital LLC1,936,000$1.62M0.0%-17.8%1.157%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC47,668$40K0.0%+38.8%0.028%Search for SEC Filing on Google Icon
11/22/2023Polar Capital Holdings Plc7,500,000$8.18M0.1%-25.0%4.483%Search for SEC Filing on Google Icon
11/15/2023GSA Capital Partners LLP621,587$0.68M0.1%N/A0.372%Search for SEC Filing on Google Icon
11/15/2023Armistice Capital LLC2,356,000$2.57M0.0%-20.8%1.408%Search for SEC Filing on Google Icon
11/14/2023Schonfeld Strategic Advisors LLC586,042$0.64M0.0%-40.4%0.350%Search for SEC Filing on Google Icon
11/14/2023Stonepine Capital Management LLC5,273,685$5.75M1.9%+14.5%3.152%Search for SEC Filing on Google Icon
11/14/2023Monashee Investment Management LLC427,265$0.47M0.2%-25.4%0.255%Search for SEC Filing on Google Icon
11/7/2023Barclays PLC382,134$0.42M0.0%+334.8%0.232%Search for SEC Filing on Google Icon
10/13/2023SG Americas Securities LLC34,340$37K0.0%N/A0.021%Search for SEC Filing on Google Icon
9/21/2023Barclays PLC87,879$0.17M0.0%N/A0.053%Search for SEC Filing on Google Icon
8/24/2023Perceptive Advisors LLC3,545,454$6.88M0.2%-22.0%2.156%Search for SEC Filing on Google Icon
8/16/2023Stonepine Capital Management LLC4,605,263$8.93M3.2%N/A3.768%Search for SEC Filing on Google Icon
8/15/2023Bain Capital Life Sciences Investors LLC15,960,588$30.96M3.2%+30.8%13.060%Search for SEC Filing on Google Icon
8/14/2023Polar Capital Holdings Plc5,000,000$9.70M0.1%N/A4.091%Search for SEC Filing on Google Icon
8/11/2023AWM Investment Company Inc.100,000$0.19M0.0%N/A0.082%Search for SEC Filing on Google Icon
8/10/2023Monashee Investment Management LLC572,784$1.11M0.3%N/A0.469%Search for SEC Filing on Google Icon
8/10/2023Private Advisor Group LLC19,800$38K0.0%N/A0.016%Search for SEC Filing on Google Icon
8/7/2023Principal Financial Group Inc.13,804$27K0.0%N/A0.011%Search for SEC Filing on Google Icon
8/7/2023Royce & Associates LP53,490$0.10M0.0%N/A0.044%Search for SEC Filing on Google Icon
8/4/2023American International Group Inc.59,261$0.12M0.0%N/A0.048%Search for SEC Filing on Google Icon
7/27/2023Virtu Financial LLC15,077$29K0.0%-86.7%0.012%Search for SEC Filing on Google Icon
7/24/2023Vontobel Holding Ltd.45,000$87K0.0%N/A0.037%Search for SEC Filing on Google Icon
7/19/2023Grimes & Company Inc.15,000$29K0.0%N/A0.012%Search for SEC Filing on Google Icon
5/15/2023Ghost Tree Capital LLC850,000$0.74M0.2%-15.0%0.696%Search for SEC Filing on Google Icon
5/12/2023Scoggin Management LP484,796$0.57M0.3%N/A0.397%Search for SEC Filing on Google Icon
5/12/2023CIBC Private Wealth Group LLC41,500$36K0.0%N/A0.034%Search for SEC Filing on Google Icon
5/10/2023Landscape Capital Management L.L.C.42,252$37K0.0%N/A0.035%Search for SEC Filing on Google Icon
5/10/2023Simplify Asset Management Inc.400,000$0.35M0.0%N/A0.327%Search for SEC Filing on Google Icon
5/1/2023Virtu Financial LLC113,489$99K0.0%N/A0.094%Search for SEC Filing on Google Icon
2/10/2023NEA Management Company LLC11,736,793$11.66M0.7%+79.9%16.952%Search for SEC Filing on Google Icon
2/7/2023Lynwood Capital Management Inc.2,155,100$2.14M2.6%N/A3.113%Search for SEC Filing on Google Icon
11/15/2022Tri Locum Partners LP2,504,006$4.28M1.2%+44.0%3.617%Search for SEC Filing on Google Icon
11/15/2022Parkman Healthcare Partners LLC950,000$1.63M0.5%N/A1.372%Search for SEC Filing on Google Icon
11/15/2022Bain Capital Life Sciences Investors LLC6,389,436$10.93M1.3%+111.6%9.228%Search for SEC Filing on Google Icon
11/14/2022NEA Management Company LLC6,523,157$11.16M0.6%N/A9.422%Search for SEC Filing on Google Icon
11/14/2022Cormorant Asset Management LP830,654$1.42M0.1%+698.9%1.200%Search for SEC Filing on Google Icon
11/14/2022Point72 Asset Management L.P.2,546,446$4.35M0.0%+55.9%3.678%Search for SEC Filing on Google Icon
11/14/2022Boothbay Fund Management LLC58,760$100K0.0%-67.3%0.085%Search for SEC Filing on Google Icon
11/14/2022AXA S.A.4,126,460$7.06M0.0%+258.7%5.960%Search for SEC Filing on Google Icon
11/10/2022Connor Clark & Lunn Investment Management Ltd.23,065$39K0.0%N/A0.033%Search for SEC Filing on Google Icon
10/17/2022LexAurum Advisors LLC16,000$27K0.0%N/A0.023%Search for SEC Filing on Google Icon
8/12/2022Ikarian Capital LLC1,679,748$1.62M0.3%+22.4%5.449%Search for SEC Filing on Google Icon
5/12/2022AIGH Capital Management LLC997,719$1.75M0.4%-31.9%3.237%Search for SEC Filing on Google Icon
4/14/2022Minot Wealth Management LLC55,000$96K0.0%N/A0.179%Search for SEC Filing on Google Icon
2/15/2022Kennedy Capital Management Inc.131,501$0.30M0.0%N/A0.532%Search for SEC Filing on Google Icon
2/14/2022Point72 Asset Management L.P.1,633,204$3.74M0.0%N/A6.610%Search for SEC Filing on Google Icon
2/14/2022Sio Capital Management LLC276,909$0.63M0.2%-65.6%1.121%Search for SEC Filing on Google Icon
2/10/2022Acadian Asset Management LLC57,270$0.13M0.0%N/A0.232%Search for SEC Filing on Google Icon
2/10/2022AIGH Capital Management LLC1,464,099$3.35M1.0%-12.0%5.926%Search for SEC Filing on Google Icon
2/10/2022Connor Clark & Lunn Investment Management Ltd.12,786$29K0.0%N/A0.052%Search for SEC Filing on Google Icon
12/29/2021Hudson Bay Capital Management LP45,893$0.24M0.0%-73.4%0.186%Search for SEC Filing on Google Icon
11/17/2021Altium Capital Management LP804,598$4.26M0.9%N/A3.256%Search for SEC Filing on Google Icon
11/15/2021Marshall Wace LLP25,223$0.13M0.0%+84.0%0.102%Search for SEC Filing on Google Icon
11/15/2021AXA S.A.590,269$3.12M0.0%+3.8%2.389%Search for SEC Filing on Google Icon
11/12/2021Trexquant Investment LP16,625$88K0.0%-34.3%0.067%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC120,394$0.64M0.0%-7.9%0.487%Search for SEC Filing on Google Icon
11/12/2021AIGH Capital Management LLC1,664,540$8.81M1.9%+15.7%6.737%Search for SEC Filing on Google Icon
11/9/2021Barclays PLC9,899$52K0.0%-39.7%0.040%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.268,450$1.42M0.0%+2.0%1.086%Search for SEC Filing on Google Icon
11/9/2021Monashee Investment Management LLC561,421$2.97M0.5%-2.3%2.272%Search for SEC Filing on Google Icon
8/27/2021Endurant Capital Management LP70,969$0.46M0.1%-53.3%0.286%Search for SEC Filing on Google Icon
8/25/2021Marshall Wace LLP13,709$89K0.0%N/A0.055%Search for SEC Filing on Google Icon
8/18/2021Ikarian Capital LLC2,719,290$17.68M1.4%+4.0%10.942%Search for SEC Filing on Google Icon
8/17/2021Worth Venture Partners LLC334,684$2.18M0.8%N/A1.347%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC386,007$2.51M0.0%N/A1.553%Search for SEC Filing on Google Icon
8/17/2021Boothbay Fund Management LLC328,209$2.13M0.1%+6.4%1.321%Search for SEC Filing on Google Icon
8/17/2021BVF Inc. IL847,879$5.51M0.2%-22.3%3.412%Search for SEC Filing on Google Icon
8/16/2021LMR Partners LLP10,152$66K0.0%N/A0.041%Search for SEC Filing on Google Icon
8/16/2021Cubist Systematic Strategies LLC13,135$85K0.0%N/A0.053%Search for SEC Filing on Google Icon
8/16/2021State Street Corp48,480$0.32M0.0%-82.5%0.195%Search for SEC Filing on Google Icon
8/16/2021Tibra Equities Europe Ltd48,400$0.32M0.1%N/A0.195%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.54,007$0.35M0.0%-35.0%0.217%Search for SEC Filing on Google Icon
8/16/2021Marshall Wace LLP13,709$89K0.0%N/A0.055%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC130,694$0.85M0.0%-16.2%0.526%Search for SEC Filing on Google Icon
8/13/2021Alpine Global Management LLC16,877$0.11M0.0%N/A0.068%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp68,563$0.45M0.0%-62.0%0.276%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC161,917$1.05M0.0%-37.3%0.652%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.897,641$5.83M0.0%+21.9%3.612%Search for SEC Filing on Google Icon
8/12/2021AIGH Capital Management LLC1,438,899$9.35M1.7%N/A5.790%Search for SEC Filing on Google Icon
8/12/2021Trexquant Investment LP25,287$0.16M0.0%N/A0.102%Search for SEC Filing on Google Icon
8/12/2021Dimensional Fund Advisors LP125,297$0.81M0.0%+164.8%0.504%Search for SEC Filing on Google Icon
8/12/2021Ergoteles LLC69,800$0.45M0.0%N/A0.281%Search for SEC Filing on Google Icon
8/11/2021Susquehanna International Group LLP38,900$0.25M0.0%N/A0.157%Search for SEC Filing on Google Icon
7/19/2021Minot Wealth Management LLC17,000$0.10M0.0%N/A0.069%Search for SEC Filing on Google Icon
5/19/2021Squarepoint Ops LLC21,078$0.18M0.0%+22.7%0.089%Search for SEC Filing on Google Icon
5/18/2021BVF Inc. IL1,091,579$9.40M0.4%+37.7%4.614%Search for SEC Filing on Google Icon
5/18/2021Orbimed Advisors LLC1,373,849$11.83M0.1%+26.4%5.808%Search for SEC Filing on Google Icon
5/17/2021Endurant Capital Management LP151,996$1.31M0.3%N/A0.643%Search for SEC Filing on Google Icon
5/17/2021DAFNA Capital Management LLC69,912$0.60M0.1%N/A0.296%Search for SEC Filing on Google Icon
5/17/2021Nuveen Asset Management LLC80,113$0.69M0.0%-4.9%0.339%Search for SEC Filing on Google Icon
5/17/2021Abingworth LLP229,885$1.96M0.7%N/A0.972%Search for SEC Filing on Google Icon
5/17/2021Ikarian Capital LLC1,235,678$10.64M0.4%+49.5%5.224%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
X4 Pharmaceuticals logo
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase III clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome; and Phase II clinical trial to treat congenital, idiopathic, or cyclic neutropenia. The company is also developing X4P-003, a CXCR4 antagonist for the treatment of CXCR4 dependent disorders and primary immunodeficiencies; and X4P-002, a CXCR4 antagonist for the treatment of blood-brain barrier diseases. It has a license agreement with Abbisko Therapeutics Co Ltd. to develop, manufacture, and commercialize mavorixafor in combination with checkpoint inhibitors or other agents in oncology indications. The company is headquartered in Boston, Massachusetts.
Read More on X4 Pharmaceuticals

Today's Range

Now: $0.98
Low: $0.97
High: $1.03

50 Day Range

MA: $1.09
Low: $0.90
High: $1.36

52 Week Range

Now: $0.98
Low: $0.57
High: $2.13

Volume

654,726 shs

Average Volume

2,392,838 shs

Market Capitalization

$164.01 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.4

Who are the company insiders with the largest holdings of X4 Pharmaceuticals?

X4 Pharmaceuticals' top insider shareholders include:
  1. Paula Ragan (CEO)
  2. Mary Dibiase (COO)
  3. Arthur Taveras (Insider)
  4. Murray Stewart (Insider)
  5. Adam S Mostafa (CFO)
  6. Michael S Wyzga (Director)
  7. Mark Baldry (Insider)
  8. Adam S Mostafa (CFO)
Learn More about top insider investors at X4 Pharmaceuticals.

Who are the major institutional investors of X4 Pharmaceuticals?

X4 Pharmaceuticals' top institutional investors include:
  1. Vanguard Group Inc. — 4.66%
  2. GSA Capital Partners LLP — 0.19%
  3. BNP Paribas Financial Markets — 0.04%
  4. Price T Rowe Associates Inc. MD — 0.02%
  5. SG Americas Securities LLC — 0.01%
Learn More about top institutional investors of X4 Pharmaceuticals stock.

Which major investors are selling X4 Pharmaceuticals stock?

During the last quarter, XFOR stock was sold by these institutional investors:
  1. GSA Capital Partners LLP
  2. BNP Paribas Financial Markets
  3. Vanguard Group Inc.
  4. SG Americas Securities LLC
In the last year, company insiders that have sold X4 Pharmaceuticals company stock include:
  1. Paula Ragan (CEO)
  2. Mary Dibiase (COO)
  3. Arthur Taveras (Insider)
  4. Murray Stewart (Insider)
  5. Adam S Mostafa (CFO)
  6. Michael S Wyzga (Director)
  7. Mark Baldry (Insider)
Learn More investors selling X4 Pharmaceuticals stock.

Which major investors are buying X4 Pharmaceuticals stock?

In the last quarter, XFOR stock was purchased by institutional investors including:
  1. Price T Rowe Associates Inc. MD